Estudiado en personas
Existen estudios publicados en personas. No es un medicamento autorizado en Estados Unidos ni en la Unión Europea.
Esta página es un esbozo
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
Qué tan sólida es la evidencia
Hasta dónde ha llegado
Todo medicamento sube la misma escalera. La mayoría de los compuestos nunca llega a lo más alto, y el lugar que ocupa indica cuánto pueden sostener sus afirmaciones.
- Medicamento autorizado
Un regulador ha revisado los ensayos y lo ha autorizado para un uso concreto.
- Fase 3
Ensayos aleatorizados grandes, a menudo con miles de personas, frente a placebo o un tratamiento estándar.
- Fase 2
Ensayos de tamaño medio que miden la dosis frente al efecto en personas con la enfermedad.
- Fase 1 y estudios humanos iniciales: Melanotan II
Primeros estudios en personas: seguridad y cómo el organismo lo procesa.
- Células y animales
Trabajo de laboratorio y con animales. Un resultado en animales no es un resultado en personas.
- 624
- artículos en PubMed
- 182
- de ellos en personas
- 1
- ensayos aleatorizados
- 34
- revisiones
Un recuento indica cuánto se ha publicado, no lo que encontró. Contado en PubMed: 2026-11-16
Manipulación y reconstitución
Del polvo a una muestra medida
Los mismos cuatro pasos para cualquier vial liofilizado. Manipulación de laboratorio, no uso en una persona.
1. Lea el vial
La etiqueta indica la masa de péptido en el vial, en miligramos. Ese número es el punto de partida de todo cálculo.
2. Añada el diluyente
Se añade un volumen medido de diluyente lentamente, por la pared del vidrio. Haga girar con suavidad; agitar puede dañar un péptido.
3. Calcule la concentración
La concentración es la masa dividida por el volumen: 10 mg en 2 mL son 5 mg por mL.
4. Mida la muestra
El volumen es la masa deseada dividida por la concentración. En una jeringa U-100, 1 mL equivale a 100 unidades.
La calculadora de abajo hace la aritmética y muestra el procedimiento.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on Melanotan II itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Melanotan II; no amount here is a recommendation.
Melanotan II: en PubMed
What PubMed held for Melanotan II on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 624
- papers
- 182
- in humans
- 5
- clinical trials
- 1
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
TrialDorr RT, Lines R, Levine N, et al. Life sciences, 1996. PMID 8637402
- Effect of Treatment Modalities on Progression-Free Survival and Overall Survival in Molecularly Subtyped World Health Organization Grade II Diffuse Gliomas: A Systematic Review
ReviewGhaffari-Rafi A, Samandouras G World neurosurgery, 2020. PMID 31473344
- Peptides for male sexual dysfunction: a systematic review of emerging evidence
ReviewRamez M, Mostafa MM, Mohamed H, et al. The journal of sexual medicine, 2026. PMID 43002584
- Exercise-induced metallothionein expression in human skeletal muscle fibres
TrialPenkowa M, Keller P, Keller C, et al. Experimental physiology, 2005. PMID 15640275
- Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study
TrialWessells H, Fuciarelli K, Hansen J, et al. The Journal of urology, 1998. PMID 9679884
- Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II
TrialWessells H, Levine N, Hadley ME, et al. International journal of impotence research, 2000. PMID 11035391
- Metallothionein in Brain Disorders
ReviewJuárez-Rebollar D, Rios C, Nava-Ruíz C, et al. Oxidative medicine and cellular longevity, 2017. PMID 29085556
- CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists
StudyTomassi S, Dimmito MP, Cai M, et al. Journal of medicinal chemistry, 2022. PMID 35188390
Search used: ("melanotan II"[tiab] OR "melanotan-II"[tiab] OR "MT-II"[tiab]). Run it on PubMed
Enlaces de investigación
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for Melanotan II on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.